Investor · Chicago, IL
Matthew Goebel
Open Matthew in the network graph →Capital
$55.6M
across filings
Active
Nov 2018
to Mar 2020
Most-connected co-filers (59)
William Bennett · Chicago, IL7 sharedRobert Saunders · Chicago, IL7 sharedSean Lavies · Indianapolis, IN4 sharedEdward Mathers · Cambridge, MA4 sharedAxel Bolte · Boston, MA4 sharedHarley Miller · Brooklyn, NY4 sharedGGV Discovery II L.L.C · Menlo Park, CA4 sharedSean Mullins · Indianapolis, IN4 sharedRob Hopfner · Boston, MA4 sharedMartin Edwards · Philadelphia, PA4 sharedJoseph Schlessinger · Boston, MA4 sharedEric Huebner · Carmel, IN4 sharedRobert D. Ghiselli · Glendale, CO4 sharedAndrew Denardo · Red Bank, NJ4 sharedMichael J. Hughes · Evanston, IL4 sharedDaniel J. Hopkins · Evanston, IL4 sharedReinaldo Diaz · Boston, MA4 sharedBen Cicora · Kalamazoo, MI3 sharedMichael J. Carlotti · VANCOUVER, British Columbia, Canada3 sharedJoel S. Wallskog · Milwaukee, WI3 sharedJohn Dover · VANCOUVER, British Columbia, Canada3 sharedNavjot S. Kohli · Milwaukee, WI3 sharedLogan S. Brigman · Milwaukee, WI3 sharedMorgan C. Frank · SAN DIEGO, CA3 shared Recent filings (17)
Woven Brands, LLCSep 2022 · 2 co-filers$1.5MWoven Brands, LLCSep 2022 · 2 co-filers$1.5MTCI Acquisition Company, Inc.Dec 2021 · 11 co-filers$30.0MCleverPet, Inc.May 2021 · 5 co-filers$3.0MTCI Acquisition Company, Inc.May 2021 · 7 co-filers$2.0MCleverPet, Inc.May 2021 · 5 co-filers$3.0MInozyme Pharma, Inc.Mar 2020 · 20 co-filers$33.7MNovel Coworking Fund III - A, LPMar 2020 · 10 co-filers$162.5MNovel Coworking Fund III - I, LPMar 2020 · 10 co-filers$162.5MNovel Coworking Fund III - B, LPMar 2020 · 10 co-filers$25.1MWoven Brands, LLCJul 2019$250KInozyme Pharma, Inc.Mar 2019 · 20 co-filers$33.7MAUSTRALIS CAPITAL INCNov 2018 · 14 co-filers$62KAUSTRALIS CAPITAL INCNov 2018 · 14 co-filers$474KInozyme Pharma, Inc.Nov 2018 · 17 co-filers$48.9MInozyme Pharma, Inc.Nov 2018 · 17 co-filers$10.7MAUSTRALIS CAPITAL INCNov 2018 · 16 co-filers$2.7M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →